A CONCURRENT RESOLUTION urging the United States Congress to allow users of medical cannabis to own firearms.
Summary
HCR19 is a concurrent resolution that urges the United States Congress to change federal law so that people who use medical cannabis are not barred from purchasing or possessing firearms. The resolution states that current federal firearms law prohibits possession by unlawful users of controlled substances, that cannabis remains a controlled substance under federal law, and that this creates a conflict for patients using medical cannabis under state law. It specifically references Kentucky’s medical cannabis program, enacted in Senate Bill 47 and effective January 1, 2025, as part of the reason the issue has become more immediate in the Commonwealth.
The resolution does not change Kentucky statutes or create a new state-level firearms or cannabis rule. Instead, it is a formal expression of the General Assembly’s position and a request that Congress address the federal-state conflict. It directs the House Clerk to transmit the resolution to congressional leaders and Kentucky’s congressional delegation, signaling that the intended effect is advocacy at the federal level rather than direct regulatory action in Kentucky.
The general sentiment reflected in the bill text is supportive of medical cannabis users and strongly protective of Second Amendment rights. The resolution frames the current federal rule as creating confusion, inconsistency, and unnecessary legal risk for people who are following state medical cannabis law but still want to exercise their right to keep and bear arms. The tone is conciliatory toward Congress but clearly urges a policy change.
Because there are no committee transcripts or recorded votes provided, there is no documented debate or formal opposition in the supplied materials. The main point of contention inherent in the resolution is the conflict between federal firearms restrictions tied to controlled-substance use and state-authorized medical cannabis access. The bill’s supporters appear to view that conflict as unfair to patients, while the underlying federal framework reflects the opposite concern: restricting firearms access for users of a federally controlled substance.
Impact
HCR19 has no direct effect on Kentucky statutes, criminal law, firearms law, or the state medical cannabis program. Its practical impact is limited to expressing legislative intent and urging federal action. If Congress were to act on the request, the change would affect federal firearms eligibility rules for medical cannabis users and could reduce legal uncertainty for patients in Kentucky and other states with medical cannabis laws.
Sentiment
The bill text reflects a favorable sentiment toward medical cannabis patients and toward firearm ownership rights. It presents the issue as a conflict that should be resolved in favor of allowing lawful medical cannabis users to purchase and possess firearms, and it frames the current federal rule as burdensome and inconsistent with state policy. No votes or committee discussion were provided, so there is no evidence of recorded opposition or amendment activity in the supplied record.
Contention
The central contention is the clash between federal firearms law and state medical cannabis laws. Supporters of the resolution argue that patients should not have to choose between medical treatment and gun rights, and that the current federal rule creates confusion and unnecessary risk. The opposing policy concern, implicit in the existing federal prohibition, is that users of a federally controlled substance should remain restricted from firearm possession. The resolution does not resolve that conflict itself; it asks Congress to do so.